Schroder Investment Management Group Portfolio holdings
AUM
$118B
1-Year Return
26.33%
This Quarter Return
+12.31%
1 Year Return
+26.33%
3 Year Return
+110.68%
5 Year Return
+193.29%
10 Year Return
+454%
AUM
$85B
AUM Growth
+$7.88B
(+10%)
Cap. Flow
+$197M
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
26.26%
Holding
1,293
New
96
Increased
491
Reduced
483
Closed
88
Top Buys
| 1 |
Vale
VALE
|
+$307M |
| 2 |
Liberty Media Series C
FWONK
|
+$303M |
| 3 |
Emerson Electric
EMR
|
+$283M |
| 4 |
Salesforce
CRM
|
+$249M |
| 5 |
Uber
UBER
|
+$208M |
Top Sells
| 1 |
Arm
ARM
|
+$393M |
| 2 |
HDFC Bank
HDB
|
+$257M |
| 3 |
Johnson Controls International
JCI
|
+$232M |
| 4 |
UnitedHealth
UNH
|
+$208M |
| 5 |
Oracle
ORCL
|
+$194M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Consumer Discretionary | 13.52% |
| 3 | Financials | 12.3% |
| 4 | Healthcare | 12% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Trimble
TRMB
$19.3B
| $2.84M | ﹤0.01% |
44,188
-1,989
| -4% | -$128K |
|
827
Edison International
EIX
$20.5B
| $2.83M | ﹤0.01% |
40,024
+2,569
| +7% | +$182K |
|
828
VICI Properties
VICI
$35.5B
| $2.76M | ﹤0.01% |
92,802
-9,337
| -9% | -$278K |
|
829
Texas Pacific Land
TPL
$21B
| $2.75M | ﹤0.01% |
4,749
-45
| -0.9% | -$26K |
|
830
argenx
ARGX
$47B
| $2.74M | ﹤0.01% |
6,951
-6,237
| -47% | -$2.46M |
|
831
Check Point Software Technologies
CHKP
$21.1B
| $2.7M | ﹤0.01% |
16,442
-17
| -0.1% | -$2.79K |
|
832
Okta
OKTA
$16.3B
| $2.68M | ﹤0.01% |
25,624
-64,352
| -72% | -$6.73M |
|
833
Dollar General
DG
$23.9B
| $2.66M | ﹤0.01% |
17,032
-630
| -4% | -$98.3K |
|
|
HSAI
834
Hesai Group
HSAI
$3.85B
| $2.65M | ﹤0.01% |
523,290
| – | – |
|
835
Kenvue
KVUE
$36.2B
| $2.63M | ﹤0.01% |
122,532
+5,047
| +4% | +$108K |
|
|
MRNS
836
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.62M | ﹤0.01% |
290,000
| – | – |
|
837
Amcor
AMCR
$18.9B
| $2.57M | ﹤0.01% |
270,309
+36,883
| +16% | +$351K |
|
838
Quest Diagnostics
DGX
$20.4B
| $2.56M | ﹤0.01% |
19,237
-1,243
| -6% | -$165K |
|
839
Ingersoll Rand
IR
$31.9B
| $2.54M | ﹤0.01% |
26,777
-150
| -0.6% | -$14.2K |
|
840
Zimmer Biomet
ZBH
$20.7B
| $2.54M | ﹤0.01% |
19,210
+1,729
| +10% | +$228K |
|
841
Corbus Pharmaceuticals
CRBP
$121M
| $2.53M | ﹤0.01% |
+64,503
| New | +$2.53M |
|
842
Acadia Pharmaceuticals
ACAD
$4.28B
| $2.46M | ﹤0.01% |
132,862
+71,160
| +115% | +$1.32M |
|
843
Essex Property Trust
ESS
$17.1B
| $2.41M | ﹤0.01% |
9,824
+1,969
| +25% | +$482K |
|
844
Xylem
XYL
$34.1B
| $2.4M | ﹤0.01% |
18,545
-201
| -1% | -$26K |
|
845
Intellia Therapeutics
NTLA
$1.28B
| $2.39M | ﹤0.01% |
86,925
-1,577
| -2% | -$43.4K |
|
846
Healthcare Realty
HR
$6.4B
| $2.39M | ﹤0.01% |
168,895
+70,705
| +72% | +$1M |
|
847
Apellis Pharmaceuticals
APLS
$3.4B
| $2.37M | ﹤0.01% |
40,403
+16,721
| +71% | +$983K |
|
848
iShares MSCI World ETF
URTH
$5.66B
| $2.37M | ﹤0.01% |
16,377
-19,291
| -54% | -$2.8M |
|
849
Royal Caribbean
RCL
$93.8B
| $2.37M | ﹤0.01% |
17,050
+13
| +0.1% | +$1.81K |
|
850
PG&E
PCG
$32.9B
| $2.36M | ﹤0.01% |
140,605
-1,124
| -0.8% | -$18.8K |
|